Problem Management Scenario # 2 September 17,2005.

Slides:



Advertisements
Similar presentations
Tips to a Successful Monitoring Visit
Advertisements

Checking & Corrective Action
EOC: Semi-Annual Review of DOH Survey Citations, The Top 10!
Kenya AIDS Vaccine Initiative
World Health Organization
Regulatory Challenges in the Cell Preparation Facility Adrian Gee Center for Cell & Gene Therapy Regulatory Challenges in the Cell Preparation Facility.
Good Manufacturing Practices Guilin, PRC Dr AJ van Zyl for Quality Assurance and Safety: Medicines Medicines Policy and Standards Health Technology and.
Complying with FSMA: What a cashew exporter to the U.S. needs to do.
GTP Scenario # 2 September 17,2005. Scenario # 2 Dr. Good received IND approval for CD8 depletion of allogeneic PBMC for a Phase I/II clinical trial.
IFSQN CODEX and Good Manufacturing Practice Training Guide.
Corrective & Preventive Action Programme l Corrective and preventive action managed by one programme l Closely linked to the internal audit programme l.
LAV Process Explained: Equipment Maintenance Medical Equipment and Logistics Solutions Directorate Naval Medical Logistics Command.
HANDLING A FOOD RECALL AND BATCH COOKING. Overview How does LAUSD handle food recalls Instructions for batch cooking and why it is important.
FIELD COMPLIANCE UPDATE CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.
External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.
QC/QA Mary Malarkey Director, Division of Case Management Office of Compliance and Biologics Quality Center for Biologics Evaluation and Research March.
ISO Standard is based on the management model of plan – do - check – act. Today we all be discussing the elements of the standard that deal with.
Rob Packard, President Slide 1 of 23 Bioburden Failure Analysis An E. coli strain being plated for identification.
Rob Packard, President Slide 1 of 30 Bioburden Failure Analysis An E. coli strain being plated for identification.
Water | Slide 1 of 16 January 2006 Water for Pharmaceutical Use Part 4: Commissioning, Qualification and validation Supplementary Training Modules on Good.
4. Quality Management System (QMS)
GOOD MANUFACTURING PRACTICES Training about our Food Safety Plan
World Health Organization
Top Tactics for Maximizing GMP Compliance in Blue Mountain RAM Jake Jacanin, Regional Sales Manager September 18, 2013.
Qualification of HVAC systems
QC | Slide 1 of 16 June 2006 Good Practices for Quality Control Laboratories P art 4: Inspecting the laboratory Supplementary Training Modules on Good.
4. Quality Management System (QMS)
Supplier Overview of Johnson & Johnson MD&D Supplier Quality Standard Operating Procedures (SOPs) Supplier Business Reviews.
United States Department of Agriculture Food Safety Inspection Service SALMONELLA SUBTYPING RESULTS IN RAW PRODUCTS FSIS Notice /3/2010 Policy Development.
World Health Organization
Good Laboratory Practice
After the Sanitary Survey
CBER Review Considerations on Source Plasma Vaccination Programs Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.
Inspection Issues in the Analytical Laboratory: An FDA Perspective Yvonne McKnight Chemist US Food and Drug AdministrationPhone: x
Water | Slide 1 of Water for Pharmaceutical Use Part 3: Operational considerations Supplementary Training Modules on Good Manufacturing Practice.
Support Programs version 2 March 2010 Cleaning and Sanitation
Occurrence Reports. An occurrence report is a document used to record an event when it occurs Occurrences are reported each time an occurrence occurs.
World Health Organization
Management of IMP in Pharmacy Peter Fox STAKT Investigator Meeting Research & Development Pharmacy Services.
Welcome to Food Safety Plan Documentation and Record Keeping Heidi Dupuis, RD, SFNS ODE – Child Nutrition Ode.state.or.us/services/nutrition.
9 - 2 Hazard Analysis Critical Control Point 9 - The HACCP Philosophy 3 Prevented Eliminated Reduced to safe levels If significant biological, chemical,
Aloe Vera of America: A Quality IASC-Certified Producer of Aloe Vera Presented by Walt Jones.
ISO NON-CONFORMANCE, CORRECTIVE AND PREVENTIVE ACTION.
Inspection Directions: An EMS Approach to Inspecting for Section 608 and 609 Compliance.
Proposed Rule for Preventive Controls for Animal Food.
Proposed Rule: 21 CFR 507 Proposed Rule for Preventive Controls for Animal Food 1.
© 2011 Michigan State University and United Nations Industrial Development Organization, original at CC-BY-SA HACCP Principle.
Why do we need to do it? What are the basic tools?
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
Occurrence Reports. An occurrence report is a document used to record an event when it occurs Occurrences are reported each time an occurrence occurs.
Dispensary and Administration Site Information Presentation.
Validation | Slide 1 of 27 August 2006 Validation Supplementary Training Modules on Good Manufacturing Practice WHO Technical Report Series, No. 937, 2006.
IHE PCD MEM-DMC CMMS & RTLS User Perspective Monroe Pattillo Practical Health Interoperability, LLC 6/21/2013.
Comparability Protocols Lore Fields MT(ASCP)SBB Consumer Safety Officer DBA/OBRR/CBER September 16, 2009.
Final Rule for Preventive Controls for Animal Food 1 THE FUTURE IS NOW.
CBER Common Problems on Source Plasma Inspections Judy Ellen Ciaraldi BS, MT(ASCP)SBB, CQA(ASQ) CBER, OBRR, DBA September 16, 2009.
Office of Human Research Protection Georgia Health Sciences University.
Checking and Corrective Action EPA Regions 9 & 10 and The Federal Network for Sustainability 2005.
NANCY CHOBIN, RN, AAS, ACSP, CSPM, CFER CHOBIN & ASSOCIATES CONSULTING HOT TOPICS IN STERILIZATION AND DISINFECTION.
Responsibilities of Sponsor, Investigator and Monitor
Quality Assurance.
BSB Biomanufacturing CHAPTER 4 GMP – Documentation Part I (SOP)
World Health Organization
Responsibilities of Sponsor, Investigator and Monitor
Author: Nurul Azyyati Sabri
Water for Pharmaceutical Use
CQA Producer Registration System
The Quality System Inspection Technique (QSIT)
Food Safety Management Systems
Presentation transcript:

Problem Management Scenario # 2 September 17,2005

Scenario # 2 Weekly EM (static readings, at rest) in one of the facility’s BSCs is outside the acceptable range. Weekly EM (static readings, at rest) in one of the facility’s BSCs is outside the acceptable range. What do you do? What do you do?

General Investigational Approach Determine the severity of the excursion. Determine the severity of the excursion. Evaluate recent trending data. Evaluate recent trending data. Initiate investigation: limited or full Initiate investigation: limited or full Identify products processed in BSC. Identify products processed in BSC. Review sterility results for affected products. Review sterility results for affected products. Based on investigation results, evaluate potential impact on products, patients & operations. Based on investigation results, evaluate potential impact on products, patients & operations.

What should be done if… Alert level is exceeded for either the particle counts or the viable air sample. Alert level is exceeded for either the particle counts or the viable air sample.

Alert Level Exceeded: Investigation Limited investigation to include: Limited investigation to include: Inspect cleanliness of BSC and adjacent areas Inspect cleanliness of BSC and adjacent areas Review BSC equipment log (maintenance & cleaning records, calibration date) Review BSC equipment log (maintenance & cleaning records, calibration date) Review EM trending data for the BSC Review EM trending data for the BSC Review sampling device PM & calibration Review sampling device PM & calibration Identification of organism (if viable air sample in question) Identification of organism (if viable air sample in question)

Alert Level Exceeded: Follow-Up Document the investigation and any corrective/preventative actions. Document the investigation and any corrective/preventative actions. If problems identified, possible actions include: If problems identified, possible actions include: BSC Service to verify proper operation – remove from service if fails BSC Service to verify proper operation – remove from service if fails Revision of BSC cleaning procedure Revision of BSC cleaning procedure Increased monitoring frequency and sites Increased monitoring frequency and sites Staff retraining Staff retraining

Alert Level Exceeded: Follow-Up Ensure product document includes a cross-reference of the investigation document. Ensure product document includes a cross-reference of the investigation document. Affected Products: Investigation should determine if stored products are suitable for use. Affected Products: Investigation should determine if stored products are suitable for use. Product recall unlikely unless BSC malfunction identified. Product recall unlikely unless BSC malfunction identified.

What should be done if… Action level is exceeded for either the particle counts or the viable air sample. Action level is exceeded for either the particle counts or the viable air sample.

Action Level Exceeded: Investigation Limited or full investigation depending on product, processing, trending data, size of excursion Limited or full investigation depending on product, processing, trending data, size of excursion Same as for Alert Level Investigation Same as for Alert Level Investigation Possible additional actions include: Possible additional actions include: Verify proper operation of BSC, sampling device Verify proper operation of BSC, sampling device Remove hood from service if excursion serious or BSC fails verification Remove hood from service if excursion serious or BSC fails verification Thoroughly clean & sanitize BSC Thoroughly clean & sanitize BSC Increase monitoring frequency and sites Increase monitoring frequency and sites Evaluate EM trending for adjacent areas Evaluate EM trending for adjacent areas

Action Level Exceeded: Follow-Up Same as for the Alert Limit Scenario. Same as for the Alert Limit Scenario. Follow Deviation Reporting SOP to notify appropriate medical/ reporting groups Follow Deviation Reporting SOP to notify appropriate medical/ reporting groups May consider product ‘recall’ based on conclusions of investigation (e.g. organisms identified, nature of BSC malfunction). May consider product ‘recall’ based on conclusions of investigation (e.g. organisms identified, nature of BSC malfunction). Immediately notify FDA district office if recall intended. Immediately notify FDA district office if recall intended.